Airway responsiveness in chronic obstructive pulmonary disease

      This paper is only available as a PDF. To read, Please Download here.


      Airway resistance measured at FRC (functional residual capacity) and related to a specific thoracic gas volume (Vtg × Raw) by plethysmographic technic is the most sensitive measurement, among other currently used measurements, of the effectiveness of bronchodilator drugs. The product Vtg × Raw (thoracic gas volume × airway resistance) is shown to correlate best with the MEFR (maximal expiratory flow rate) in a group of normal subjects. In patients with chronic obstructive lung disease there is a significant negative correlation between Vtg × Raw and the MEFR, FEV1 (one second forced expiratory volume) and MMF (maximal mid-flow).
      A group of selected patients with chronic obstructive lung disease, exclusive of bronchial asthma, demonstrated significant responsiveness of the airway to bronchodilator drugs, indicating that airway obstruction is not “fixed” in these subjects. Isoproterenol delivered directly to the bronchial tree by IPPB (intermittent positive pressure breathing) produced statistically significant reduction in the product Vtg × Raw. Comparable reduction was noted in the normal group. Epinephrine given subcutaneously in a 0.3 ml. dose produced greater favorable changes in Vtg × Raw than did 0.5 gm. theophyllin injected intravenously. Neither drug produced statistically significant reductions in Vtg × Raw when compared to IPPB with saline solution.
      Theophyllin administered intravenously and isoproterenol by IPPB resulted in statistically significant improvement in spirometric indices of ventilation in the patient group when compared to the results of the use of these drugs in normal subjects. Since isoproterenol produced significant effects on the airways and theophyllin did not, the spirometric improvement following the administration of theophyllin is attributed, in part, to the effects of this drug on other organ systems. Normal subjects fail to show supernormal spirometric performance following the use of IPPB with isoproterenol.
      When diffuse obstructive pulmonary disease is present, the response to broncho-dilators is reflected by spirometric improvement to variable degrees. The factors in the underlying lung mechanics in the normal and patient groups are discussed to suggest an explanation for this apparent discrepancy in spirometric improvement.
      The usefulness of bronchodilator therapy in chronic obstructive pulmonary disease is confirmed and a wide range of individual variation is demonstrated. The necessity for choice of a sensitive measurement technic and statistical evaluation of therapeutic agents in chronic obstructive pulmonary disease is emphasized.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • American Thoracic Society
        Statement by the Committee on Therapy: Chronic Obstructive Lung Disease.
        Am. Rev. Resp. Dis. 1965; 92: 513
        • Boren H.G.
        Principles and practical aspects of therapy of chronic pulmonary insufficiency.
        in: 11th ed. Textbook of Pulmonary Diseases. Little Brown & Co, Boston1965: 460 (chap. 21)
        • Miller W.F.
        Chronic pulmonary emphysema.
        in: Current Therapy. W. B. Saunders Co, Philadelphia and London1965: 85 (sect. 2)
        • American Thoracic Society
        Statement by the Committee on Diagnostic Standards for Nontuberculous Respiratory Disease: Definitions and Classification of Chronic Bronchitis, Asthma and Pulmonary Emphysema.
        Am. Rev. Resp. Dis. 1963; 87: 216
        • Fletcher C.M.
        • Jones N.L.
        • Burrows B.
        • Niden A.H.
        American emphysema and British bronchitis: a standardized comparative study.
        Am. Rev. Resp. Dis. 1964; 90: 1
        • Burrows B.
        • Niden A.H.
        • Fletcher C.M.
        • Jones N.L.
        Clinical types of chronic obstructive lung disease in London and in Chicago. A study of 100 patients.
        Am. Rev. Resp. Dis. 1964; 90: 14
        • Ebert R.V.
        Chronic bronchitis and pulmonary emphysema.
        in: 11th ed. Cecil and Loeb Textbook of Medicine. W. B. Saunders Co, Philadelphia and London1963: 537
        • Kory R.C.
        • Callahan R.
        • Boren H.G.
        • Snyder J.C.
        Administration—Army cooperative study of pulmonary function. I. Clinical spirometry in normal man.
        Am. J. Med. 1961; 30: 243
        • Darling R.C.
        • Cournand A.
        • Richards Jr., D.W.
        Studies on intrapulmonary mixture of gases. III. Open circuit method for measuring residual air.
        J. Clin. Invest. 1940; 19: 609
        • Comroe Jr., J.H.
        3rd ed. Methods in Medical Research. vol. 2. Year Book Publishers, Chicago1950: 209
        • DuBois A.B.
        • Botelho S.Y.
        • Bedell G.N.
        • Marshall R.
        • Comroe Jr., J.H.
        A rapid plethysmographic method for measuring thoracic gas volume. A comparison with a nitrogen washout method for measuring functional residual capacity in normal subjects.
        J. Clin. Invest. 1956; 35: 322
        • DuBois A.B.
        • Botelho S.Y.
        • Comroe Jr., J.H.
        A new method for measuring airway resistance in man using a body plethysmograph. Values in normal subjects and in patients with respiratory disease.
        J. Clin. Invest. 1956; 35: 327
        • Emmanuel G.
        • Briscoe W.A.
        • Cournand A.
        A method for the determination of the volume of air in the lungs. Measurements in chronic pulmonary emphysema.
        J. Clin. Invest. 1961; 40: 329
        • Lloyd Jr., T.C.
        • Wright G.W.
        Evaluation of methods used in detecting changes of airway resistance in man.
        Am. Rev. Resp. Dis. 1963; 87: 529
        • Briscoe W.A.
        • DuBois A.B.
        The relationship between airway resistance, airway conductance and lung volume in subjects of different age and body size.
        J. Clin. Invest. 1958; 37: 1279
        • Bedell G.N.
        • Marshall R.
        • DuBois A.B.
        • Comroe Jr., J.H.
        Plethysmographic determination of the volume of gas trapped in the lungs.
        J. Clin. Invest. 1956; 35: 664
        • Ross J.C.
        • Copher D.E.
        • Teays J.D.
        • Lord T.J.
        Functional residual capacity in patients with pulmonary emphysema. A comparative study using gas dilution and plethysmographic techniques for measurement.
        Ann. Int. Med. 1962; 57: 18
        • Stein M.
        • Tanabe G.
        • Rege V.
        • Khan M.
        Evaluation of spirometric methods used to assess abnormalities in airway resistance.
        Am. Rev. Resp. Dis. 1966; 93: 257
        • Dawson A.
        Reproducibility of spirometric measurements in normal subjects.
        Am. Rev. Resp. Dis. 1966; 93: 264
        • Steel R.G.D.
        • Torrie J.H.
        Principles and procedures of statistics.
        in: McGraw Hill Book Co, New York, Toronto and London1960: 110
      1. Pearson E.S. Hartley H.O. Biometrika Tables. The University Press, Cambridge and London1954: 136 (table 11)
        • Dautrebande L.
        • Lovejoy Jr., F.W.
        • Constantine H.
        New studies on aerosols. XI. Comparative study of some methods used for determining constriction and dilation of the airways after administering pharmacological or dust aerosols, sensitivity of the plethysmograph method.
        Arch. Int. Pharmacodyn. 1960; 129: 469
        • Cohen A.A.
        • Hale F.C.
        Comparative effects of isoproterenol aerosols on airway resistance in obstructive pulmonary disease.
        Am. J. Med. Sc. 1965; 249: 309
        • Mead J.
        Volume displacement body plethysmograph for respiratory measurements in human subjects.
        J. Appl. Physiol. 1960; 15: 736
        • Hyatt R.E.
        • Schilder D.P.
        • Fry D.L.
        Relationship between maximum expiratory flow and degree of lung inflation.
        J. Appl. Physiol. 1958; 13: 331
        • Fry D.L.
        • Hyatt R.E.
        Pulmonary mechanics: a unified analysis of the relationship between pressure, volume and gasflow in the lungs of normal and diseased human subjects.
        Am. J. Med. 1960; 29: 672
        • Bartlett Jr., R.G.
        • Brubach H.F.
        • Trimble R.C.
        • Specht H.
        Airway resistance measurement during any breathing pattern in man.
        J. Appl. Physiol. 1959; 14: 89
        • Wilkes E.A.
        • Chester E.H.
        • Payne Jr., C.B.
        Dynamic airway resistance measurement by plethysmograph.
        (Abstract.)in: 3rd ed. Proceedings of 18th Annual Conference on Engineering in Medicine and Biology. vol. 7. 1965: 91
        • Rohrer F.
        Der Strömungswiderstand in den menschlicher Atemwegen.
        Arch. f.d. Ges. Physiol. 1915; 162: 225
      2. Wilkes, E. A., Chester, E. H. and Payne, C. B. Jr. Unpublished data.

        • Butler J.C.
        • Caro C.G.
        • Alcala R.
        • DuBois A.B.
        Physiological factors affecting airway resistance in normal subjects and in patients with obstructive respiratory disease.
        J. Clin. Invest. 1960; 39: 584
        • DuBois A.B.
        Resistance to breathing.
        in: 3rd ed. Handbook of Physiology. vol. I. American Physiological Society, Washington, D. C1964: 451 (chap. 16)
        • Pride N.B.
        • Permutt S.
        • Riley R.L.
        The driving pressure required to attain maximal expiratory flow.
        Physiologist. 1963; 6: 257
        • Snider G.L.
        • Shapiro D.A.
        Patterns of response of spirometric indices to bronchodilator drugs in patients with obstructive lung disease.
        Am. J. M. Sc. 1965; 250: 367